Good manufacturing practice-grade cytotoxic T lymphocytes specific for latent membrane proteins (LMP)-1 and LMP2 for patients with Epstein––Barr virus-associated lymphoma

By Bollard Catherine M.   Gottschalk Stephen   Helen Huls M.   Leen Ann M.   Gee Adrian P.   Rooney Cliona M.  

Cytotherapy, Vol. 13, Iss. 5, 2011-05 ,pp. : 518-522

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Expansion of T cells targeting multiple antigens of cytomegalovirus, Epstein–Barr virus and adenovirus to provide broad antiviral specificity after stem cell transplantation

By Hanley Patrick J.   Shaffer Donald R.   Cruz Conrad R. Y.   Ku Stephanie   Tzou Benjamin   Liu Hao   Demmler-Harrison Gail   Heslop Helen E.   Rooney Clio M.   Gottschalk Stephen   Bollard Catherine M.  

Cytotherapy, Vol. 13, Iss. 8, 2011-09 ,pp. : 976-986

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Good manufacturing practice-grade production of unrestricted somatic stem cell from fresh cord blood

By Aktas Murat   Buchheiser Anja   Houben Amelie   Reimann Verena   Radke Teja   Jeltsch Kathrin   Maier Patrick   Zeller W. Jens   Kogler Gesine  

Cytotherapy, Vol. 12, Iss. 3, 2010-04 ,pp. : 338-348

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Clinical-grade varicella zoster virus-specific T cells produced for adoptive immunotherapy in hemopoietic stem cell transplant recipients

By Blyth Emily   Gaundar Shivashni S.   Clancy Leighton   Simms Renee M.   Bilmon Ian   Micklethwaite Kenneth P.   Gottlieb David J.  

Cytotherapy, Vol. 14, Iss. 6, 2012-07 ,pp. : 724-732

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Adoptive transfer of Ag-specific T cells to prevent CMV disease after allogeneic stem-cell transplantation

By van Rhee F   Barrett J  

Cytotherapy, Vol. 4, Iss. 1, 2002-01 ,pp. : 3-10

Ashgate Publishing Ltd

Access to resources Recommend Favorite